Paclitaxel Market 2026 by Types, Application, Technology

Paclitaxel Market

Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it “taxol”.Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The global Paclitaxel market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage Market Size & Forecast, Major Company of Product Type etc. :
Natural Paclitaxel
Semi-synthetic Paclitaxel
Demand Coverage Market Size & Forecast, Consumer Distribution :
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/global-paclitaxel-market-4361

Company Coverage Sales data, Main Products & Services etc. :
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI Teva
Fresenius-kabi
Southpharma
Haiyao
Huiang biopharma
Yunnan Hande
Hainan Yew Pharm
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa